JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Clinical trial NCT06882876 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06882876
- Sponsor
- Xiangya Hospital of Central South University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2027-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.